for Japanese


28 December, 2018

Japan Radioisotope Association Hopes for Increased Medical Usage of Radioisotopes

At the December 11 meeting of the Japan Atomic Energy Commission (JAEC), Executive Director Shoji Futatsukawa and other officials from the Japan Radioisotope Association (JRIA) talked about the current state of the medical use of radioisotopes and various related issues.

In addition to X-ray examinations—which use externally-generated radiation to make images of internal anatomy—examinations in nuclear medicine involve imaging using radiation sources positioned inside the body. The most common forms are positron emission tomography (PET) and single photon emission computed tomography (SPECT).

According to investigations by the JRIA, demand for higher-quality scans is on the rise, although no substantial change has been seen in the overall clinical need for nuclear medicine scans. There were approximately 580,000 domestic cases of PET usage in 2012, increasing to around 710,000 in 2017.

For SPECT examinations, which number about a million annually in Japan, all the molybdenum-99 (Mo-99)—the material used in technetic acid pharmaceutical preparation—is imported from abroad, resulting in frequent shortages of supply in Japan. Given various issues in the foreign nuclear reactors where the substance is produced, related parties in Japan have started to talk more about public-private cooperation in domestically producing Mo-99, with the Japan Society of Nuclear Medicine also making proposals in that regard.

The JRIA has emphasized that establishing a stable supply system for the material is a pressing need under the current circumstances. At that association’s initiative, the Japan Foundation of Medical Isotope Development (JAFMID) was formed in the summer of 2018 toward building a nationwide system to promote the domestic production of technetic acid pharmaceutical preparation.

Meanwhile, the JRIA, in reference to therapy using radioisotopes, has noted that the use of alpha sources has been confirmed to have curative effects in many cases. The association said that a system of global supply is being established for some radiation sources.

Referring, however, to the fact that such usage is restricted to the academic level domestically, the JRIA said, “While Japan is one of the most advanced countries in the field of nuclear medicine diagnostics, it is twenty years behind in the area of nuclear medicine therapy.”

Pointing out, also, that university facilities are using radioisotopes less and less, the JRIA made a series of proposals, as follows:

  • Further expansion of its use through the securing of a stable supply.
  • More progress in therapy using actinium-225 (an alpha source undergoing R&D outside of Japan).
  • Human-resource development and enhancement of understanding on radiation and isotopes.


This site uses Akismet to reduce spam. Learn how your comment data is processed.

SNS facebooktwitter

NPPs Map


Fukushima Daiichi Nuclear Power Station -The year in review- (March 2018 – February 2019)

8 March, 2019
Fukushima Daiichi Nuclear Power Station -The year in review- (March 2018 – February 2019)04:56

Recent News

18 June, 2019
MHI Tests Anti-Explosion Robot for Plant Inspections, Capitalizing on Experience Gained in Nuclear Accidents
13 June, 2019
Training and Simulations Mark Flawless Preparation for Start of Fuel Removal from FBR Monju Reactor Core in October
13 June, 2019
Japan’s Cabinet Approves FY18 White Paper on Energy Policy, Seeking Low-carbon Society to Meet Paris Agreement Goals
5 June, 2019
TEPCO Considering New Plan to Remove Spent Fuel from Fukushima Daiichi-2
31 May, 2019
NRA Orders Kansai EP to Backfit Takahama and Other NPPs Based on New Volcano Impact Information
31 May, 2019
Local Governments Asks National Government to Help Get Overseas Import Regulation on Foods Withdrawn or Relaxed
24 May, 2019
Japanese Power Companies to Cooperate with Each Other to Complete Anti-terrorism Facilities More Quickly
21 May, 2019
【52nd JAIF Annual Conference】 Environmental Activist Michael Shellenberger, a Pro-nuclear Convert, Meets the Press
21 May, 2019
【52nd JAIF Annual Conference】 Leader Perspective: “The Role of Nuclear Energy in the EU Low-carbon Future”
20 May, 2019
【52nd JAIF Annual Conference】 Leader Perspective: “French Nuclear Policy and Industry Update”